JZ:NASDAQJianzhi Education Technology Group Company Limited Analysis
Data as of 2026-07-07 - not real-time
$2.99
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Jianzhi Education Technology (JZ) is trading near the lower end of its 52‑week range with the 20‑day moving average well below current price, indicating limited short‑term momentum. Technical indicators show a bearish trend, RSI in the lower‑mid zone, and a bullish MACD crossover that is still modest, while volatility is extreme and beta is markedly high, suggesting the stock is prone to large swings. Recent capital‑raising via a $5 million direct offering adds dilution risk but provides needed cash, yet the company remains loss‑making with negative margins, negative cash flow, and a historic near‑100% drawdown, underscoring fundamental weakness.
The valuation metrics (price‑to‑book and price‑to‑sales) appear very low, hinting at possible undervaluation, but the lack of earnings, high regulatory exposure in China’s education sector, and thin liquidity make any upside speculative. Investors should weigh the severe downside risk against the modest price discount.
The valuation metrics (price‑to‑book and price‑to‑sales) appear very low, hinting at possible undervaluation, but the lack of earnings, high regulatory exposure in China’s education sector, and thin liquidity make any upside speculative. Investors should weigh the severe downside risk against the modest price discount.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Bearish technical trend with price below short‑term moving averages
- Extreme 30‑day volatility and high beta
- Negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Recent capital raise improves cash position
- Valuation discount relative to book and sales
- Continued regulatory uncertainty in Chinese education
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential for turnaround if margins improve
- Low price multiples may attract value‑oriented investors
- Sustained high risk from regulatory and liquidity constraints
Key Metrics & Analysis
Financial Health
Revenue Growth58.10%
Profit Margin-22.43%
ROE-38.76%
ROA-10.23%
Debt/Equity14.47
P/B Ratio3.6
Op. Cash Flow$-9745382
Free Cash Flow$-61855032
Industry P/E36.6
Technical Analysis
TrendBearish
RSI40.6
Support$2.56
Resistance$8.97
MA 20$5.04
MA 50$17.92
MA 200$31.76
MACDBullish
VolumeIncreasing
Fear & Greed Index93.63
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.88
Volatility651.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.